| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 159, Issue 3 1319-1327, Copyright © 1997 by American Association of Immunologists
ARTICLES |
KL McGuire and M Iacobelli
Department of Biology and Molecular Biology Institute, San Diego State University, CA 92182, USA. kmcguire@sunstroke.sdsu.edu
CD28 is an important costimulatory molecule in the activation of human T cells. Costimulation of T cells through both the Ag receptor and CD28 leads to high level IL-2 production, which is vital to the development of an immune response in vivo. Previous reports have suggested the CD28 stimulation contributes to the activation of the IL-2 promoter by up- regulating the activity of several transcription factors, including AP- 1 and nuclear factor-kappaB (NF-kappaB)/Rel family members as well as an uncharacterized transcription factor called CD28 response complex. While several lines of investigation have suggested that NF-kappaB/Rel family members make up the CD28 response complex transcription factor, other work has not supported this conclusion. Recent studies suggest that the CD28 response element (CD28RE) does not function independently but works instead in conjunction with the adjacent promoter proximal AP- 1-binding site and this hypothesis is confirmed here. Also in the current study, binding activity to the CD28RE/AP-1 sequence of the IL-2 promoter is evaluated. Although four specific complexes can be detected binding to this sequence, only one of these complexes is specific for both the CD28RE and the adjacent AP-1 site. Of the NF-kappaB/Rel family members tested, this CD28RE/AP-1-specific complex contains predominantly c-Rel, despite the fact that both p50 and RelA can efficiently bind to the CD28RE. c-Fos and c-Jun are also found in this CD28RE/AP-1-specific complex. These data indicate that functional complexes encompassing both the CD28RE and the AP-1-binding sites influence IL-2 promoter activity in CD28-costimulated T cells.
This article has been cited by other articles:
|
|
 |
|
  M. Sen and G. Ghosh Transcriptional Outcome of Wnt-Frizzled Signal Transduction in Inflammation: Evolving Concepts J. Immunol., October 1, 2008; 181(7): 4441 - 4445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Watanabe, Y. Harada, K. Takeda, J. Takahashi, K. Ohnuki, S. Ogawa, D. Ohgai, N. Kaibara, O. Koiwai, K. Tanabe, et al. Grb2 and Gads Exhibit Different Interactions with CD28 and Play Distinct Roles in CD28-Mediated Costimulation J. Immunol., July 15, 2006; 177(2): 1085 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. V. Parry, G. C. Whittaker, M. Sims, C. E. Edmead, M. J. Welham, and S. G. Ward Ligation of CD28 Stimulates the Formation of a Multimeric Signaling Complex Involving Grb-2-Associated Binder 2 (Gab2), Src Homology Phosphatase-2, and Phosphatidylinositol 3-Kinase: Evidence That Negative Regulation of CD28 Signaling Requires the Gab2 Pleckstrin Homology Domain J. Immunol., January 1, 2006; 176(1): 594 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sundstrom, S. Ota, L. Y. Dimberg, M. G. Masucci, and A. Bergqvist Hepatitis C Virus Core Protein Induces an Anergic State Characterized by Decreased Interleukin-2 Production and Perturbation of Mitogen-Activated Protein Kinase Responses J. Virol., February 15, 2005; 79(4): 2230 - 2239. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Y. Kang, S.-C. Miaw, and I-C. Ho ROG Negatively Regulates T-Cell Activation but Is Dispensable for Th-Cell Differentiation Mol. Cell. Biol., January 15, 2005; 25(2): 554 - 562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Falk, S. Ussat, N. Reiling, D. Wesch, D. Kabelitz, and S. Adam-Klages Caspase Inhibition Blocks Human T Cell Proliferation by Suppressing Appropriate Regulation of IL-2, CD25, and Cell Cycle-Associated Proteins J. Immunol., October 15, 2004; 173(8): 5077 - 5085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Harant and I. J. D. Lindley Negative cross-talk between the human orphan nuclear receptor Nur77/NAK-1/TR3 and nuclear factor-{kappa}B Nucleic Acids Res., October 5, 2004; 32(17): 5280 - 5290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-F. Fortin, C. Barat, Y. Beausejour, B. Barbeau, and M. J. Tremblay Hyper-responsiveness to Stimulation of Human Immunodeficiency Virus-infected CD4+ T Cells Requires Nef and Tat Virus Gene Products and Results from Higher NFAT, NF-{kappa}B, and AP-1 Induction J. Biol. Chem., September 17, 2004; 279(38): 39520 - 39531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Yui, L. L. Sharp, W. L. Havran, and E. V. Rothenberg Preferential Activation of an IL-2 Regulatory Sequence Transgene in TCR{gamma}{delta} and NKT Cells: Subset-Specific Differences in IL-2 Regulation J. Immunol., April 15, 2004; 172(8): 4691 - 4699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Dennehy, A. Kerstan, A. Bischof, J.-H. Park, S.-Y. Na, and T. Hunig Mitogenic signals through CD28 activate the protein kinase C{theta}-NF-{kappa}B pathway in primary peripheral T cells Int. Immunol., May 1, 2003; 15(5): 655 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rao, S. Gerondakis, D. Woltring, and M. F. Shannon c-Rel Is Required for Chromatin Remodeling Across the IL-2 Gene Promoter J. Immunol., April 1, 2003; 170(7): 3724 - 3731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sharma, N. Grandvaux, Y. Mamane, P. Genin, N. Azimi, T. Waldmann, and J. Hiscott Regulation of IFN Regulatory Factor 4 Expression in Human T Cell Leukemia Virus-I-Transformed T Cells J. Immunol., September 15, 2002; 169(6): 3120 - 3130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Bower, R. W. Zeller, W. Wachsman, T. Martinez, and K. L. McGuire Correlation of Transcriptional Repression by p21SNFT with Changes in DNA{middle dot}NF-AT Complex Interactions J. Biol. Chem., September 13, 2002; 277(38): 34967 - 34977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Attema, R. Reeves, V. Murray, I. Levichkin, M. D. Temple, D. J. Tremethick, and M. F. Shannon The Human IL-2 Gene Promoter Can Assemble a Positioned Nucleosome That Becomes Remodeled Upon T Cell Activation J. Immunol., September 1, 2002; 169(5): 2466 - 2476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Y. Kim and H.-S. Teh TNF Type 2 Receptor (p75) Lowers the Threshold of T Cell Activation J. Immunol., December 15, 2001; 167(12): 6812 - 6820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Abraham and J. Miller Molecular Mechanisms of IL-2 Gene Regulation Following Costimulation Through LFA-1 J. Immunol., November 1, 2001; 167(9): 5193 - 5201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. S. Shapiro, M. N. Mollenauer, and A. Weiss Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression Blood, July 1, 2001; 98(1): 187 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Kaminuma, M. Deckert, C. Elly, Y.-C. Liu, and A. Altman Vav-Rac1-Mediated Activation of the c-Jun N-Terminal Kinase/c-Jun/AP-1 Pathway Plays a Major Role in Stimulation of the Distal NFAT Site in the Interleukin-2 Gene Promoter Mol. Cell. Biol., May 1, 2001; 21(9): 3126 - 3136. [Abstract] [Full Text]
|
|
|
|
|
|
E. E. Solomou, Y.-T. Juang, and G. C. Tsokos Protein Kinase C-{{theta}} Participates in the Activation of Cyclic AMP-Responsive Element-Binding Protein and Its Subsequent Binding to the -180 Site of the IL-2 Promoter in Normal Human T Lymphocytes J. Immunol., May 1, 2001; 166(9): 5665 - 5674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-F. Fortin, B. Barbeau, G. A. Robichaud, M.-E. Pare, A.-M. Lemieux, and M. J. Tremblay Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1 Blood, April 15, 2001; 97(8): 2390 - 2400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gonzalez, C. Punzon, M. Gonzalez, and M. Fresno HIV-1 Tat Inhibits IL-2 Gene Transcription Through Qualitative and Quantitative Alterations of the Cooperative Rel/AP1 Complex Bound to the CD28RE/AP1 Composite Element of the IL-2 Promoter J. Immunol., April 1, 2001; 166(7): 4560 - 4569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Parra, T. Mustelin, M. Dohlsten, and D. Mercola Identification of a CD28 Response Element in the CD40 Ligand Promoter J. Immunol., February 15, 2001; 166(4): 2437 - 2443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Hehner, R. Breitkreutz, G. Shubinsky, H. Unsoeld, K. Schulze-Osthoff, M. L. Schmitz, and W. Droge Enhancement of T Cell Receptor Signaling by a Mild Oxidative Shift in the Intracellular Thiol Pool J. Immunol., October 15, 2000; 165(8): 4319 - 4328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Iacobelli, W. Wachsman, and K. L. McGuire Repression of IL-2 Promoter Activity by the Novel Basic Leucine Zipper p21SNFT Protein J. Immunol., July 15, 2000; 165(2): 860 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Hehner, T. G. Hofmann, O. Dienz, W. Droge, and M. L. Schmitz Tyrosine-phosphorylated Vav1 as a Point of Integration for T-cell Receptor- and CD28-mediated Activation of JNK, p38, and Interleukin-2 Transcription J. Biol. Chem., June 9, 2000; 275(24): 18160 - 18171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Lin, A. O'Mahony, Y. Mu, R. Geleziunas, and W. C. Greene Protein Kinase C-theta Participates in NF-kappa B Activation Induced by CD3-CD28 Costimulation through Selective Activation of Ikappa B Kinase beta Mol. Cell. Biol., April 15, 2000; 20(8): 2933 - 2940. [Abstract] [Full Text]
|
|
|
|
|
|
S. P. Hehner, T. G. Hofmann, A. Ushmorov, O. Dienz, I. Wing-Lan Leung, N. Lassam, C. Scheidereit, W. Dröge, and M. L. Schmitz Mixed-Lineage Kinase 3 Delivers CD3/CD28-Derived Signals into the Ikappa B Kinase Complex Mol. Cell. Biol., April 1, 2000; 20(7): 2556 - 2568. [Abstract] [Full Text]
|
|
|
|
|
|
S. R. Himes, R. Reeves, J. Attema, M. Nissen, Y. Li, and M. F. Shannon The Role of High-Mobility Group I(Y) Proteins in Expression of IL-2 and T Cell Proliferation J. Immunol., March 15, 2000; 164(6): 3157 - 3168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Powell, C. G. Lerner, G. R. Ewoldt, and R. H. Schwartz The -180 Site of the IL-2 Promoter Is the Target of CREB/CREM Binding in T Cell Anergy J. Immunol., December 15, 1999; 163(12): 6631 - 6639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Shang, J. Attema, D. Cakouros, P. N. Cockerill, and M. F. Shannon Nuclear factor of activated T cells contributes to the function of the CD28 response region of the granulocyte macrophage-colony stimulating factor promoter Int. Immunol., December 1, 1999; 11(12): 1945 - 1956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Wong, G. M. Kammer, G. Dennis, and G. C. Tsokos Abnormal NF-{kappa}B Activity in T Lymphocytes from Patients with Systemic Lupus Erythematosus Is Associated with Decreased p65-RelA Protein Expression J. Immunol., August 1, 1999; 163(3): 1682 - 1689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Ragheb, M. Deen, and R. H. Schwartz CD28-Mediated Regulation of mRNA Stability Requires Sequences Within the Coding Region of the IL-2 mRNA J. Immunol., July 1, 1999; 163(1): 120 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Kempiak, T. S. Hiura, and A. E. Nel The Jun Kinase Cascade Is Responsible for Activating the CD28 Response Element of the IL-2 Promoter: Proof of Cross-Talk with the I{kappa}B Kinase Cascade J. Immunol., March 15, 1999; 162(6): 3176 - 3187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Iacobelli, F. Rohwer, P. Shanahan, J. A. Quiroz, and K. L. McGuire IL-2-Mediated Cell Cycle Progression and Inhibition of Apoptosis Does Not Require NF-{kappa}B or Activating Protein-1 Activation in Primary Human T Cells J. Immunol., March 15, 1999; 162(6): 3308 - 3315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. S. Shapiro, M. N. Mollenauer, and A. Weiss Cutting Edge: Nuclear Factor of Activated T Cells and AP-1 Are Insufficient for IL-2 Promoter Activation: Requirement for CD28 Up-Regulation of RE/AP J. Immunol., December 15, 1998; 161(12): 6455 - 6458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Li-Weber, M. Giasi, and P. H. Krammer Involvement of Jun and Rel Proteins in Up-regulation of Interleukin-4 Gene Activity by the T Cell Accessory Molecule CD28 J. Biol. Chem., December 4, 1998; 273(49): 32460 - 32466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sundstedt and M. Dohlsten In Vivo Anergized CD4+ T Cells Have Defective Expression and Function of the Activating Protein-1 Transcription Factor J. Immunol., December 1, 1998; 161(11): 5930 - 5936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Moutouh, J. Estaquier, D. D. Richman, and J. Corbeil Molecular and Cellular Analysis of Human Immunodeficiency Virus-Induced Apoptosis in Lymphoblastoid T-Cell-Line-Expressing Wild-Type and Mutated CD4 Receptors J. Virol., October 1, 1998; 72(10): 8061 - 8072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. W. Harhaj and S.-C. Sun Ikappa B Kinases Serve as a Target of CD28 Signaling J. Biol. Chem., September 25, 1998; 273(39): 25185 - 25190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Okkenhaug and R. Rottapel Grb2 Forms an Inducible Protein Complex with CD28 through a Src Homology 3 Domain-Proline Interaction J. Biol. Chem., August 14, 1998; 273(33): 21194 - 21202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Parra, K. McGuire, G. Hedlund, and M. Dohlsten Overexpression of p65 and c-Jun Substitutes for B7-1 Costimulation by Targeting the CD28RE Within the IL-2 Promoter J. Immunol., June 1, 1998; 160(11): 5374 - 5381. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Moller, O. Dienz, S. P. Hehner, W. Droge, and M. L. Schmitz Protein Kinase C theta Cooperates with Vav1 to Induce JNK Activity in T-cells J. Biol. Chem., June 1, 2001; 276(23): 20022 - 20028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Coudronniere, M. Villalba, N. Englund, and A. Altman NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta PNAS, March 28, 2000; 97(7): 3394 - 3399. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
